Skip to search formSkip to main contentSkip to account menu

DU 6859A

Known as: DU-6859A 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
We evaluated the efficacy of a new quinolone, DU-6859a, using a new model of rat uterine endometritis. Rats were infected with… 
Review
1998
Review
1998
The development of new drugs with strong antituberculous activity and fewer side effects which are not cross-resistant to… 
1997
1997
The in-vitro antimicrobial activity of DU-6859a, a new fluoroquinolone, was tested against 55 clinical isolates of Neisseria… 
1997
1997
The activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against bite wound isolates were determined… 
Highly Cited
1996
Highly Cited
1996
MIC and time-kill methods were used to test the activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime… 
1996
1996
The effect of growth conditions on the antibacterial activity of DU-6859a against Staphylococcus auerus, Escherichia coli, and… 
Highly Cited
1995
Highly Cited
1995
Inhibitory effects of five quinolones against DNA gyrases purified from four quinolone-resistant clinical isolates of Pseudomonas… 
1995
1995
The bactericidal activity of two new 4-quinolones, DU-6859a and DV-7751a, was investigated against strains of Escherichia coli… 
1994
1994
The in vitro activity of DU-6859a (DU), a new fluoroquinolone agent, was evaluated against 233 gram-positive cocci and was… 
1993
1993
DU-6859a was tested against 844 recent clinical isolates (most from bacteremias) by using reference MIC determination procedures…